General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Janssen Pharmaceuticals, Inc(SIGNIFICANT), terumo(MODEST), Bristol-Myers Squibb Company (SIGNIFICANT), alnylam(SIGNIFICANT), AstraZeneca Pharmaceuticals(MODEST), imbria(MODEST), cytokinetics(SIGNIFICANT), bridgebio(NONE) OFFICER, DIRECTOR ETC: Blue Cross Blue Shield of Kansas City(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Copyright for SAQ, KCCQ and PAQ(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: American College of Cardiology Foundation(SIGNIFICANT)

View Full Disclosure